Without that data, we simply don't have a complete picture of its side effects, optimal dosing, or long-term health impacts in humans
flexible ratios Cycle driver Whichever compound titrates more slowly Cagrilintide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Semaglutide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Weekly Schedule Example (Maintenance) Same day each week Cagrilintide 2.4 mg SubQ + Semaglutide 2.4 mg SubQ Use separate syringes for each compound
This step prevents the mixing solution from spraying violently into the vial
doi: 10.1093/rheumatology/kep080
How to properly reconstitute and handle Cagrilintide lyophilized powder
It is not cleared, manufactured, or sterilized for in vivo experimentation, animal administration, or therapeutic trials